1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Global Proton Therapy Market and Centers Analysis

Global Proton Therapy Market and Centers Analysis

  • December 2014
  • -
  • Igate Research
  • -
  • 126 pages

Proton beam therapy is going through an interesting period right now as the unprecedented demand of proton therapy for the treatment of cancer has set the stage for the market to move ahead at a rapid pace. Proton therapy is a type of particle therapy which is used to treat cancer patients by means of proton beams irradiation. The main advantage of proton therapy is that while destroying the target malignant cells, it causes minimal damage to the surrounding cells. Proton therapy uses the ionization technique to inhibit cell proliferation. Protons move slowly through the body and interact with electrons and discharge energy. At a cost of US$ 125 Million, and sometimes much more, todays centers usually fill a city block. Building and equipping a facility carries financial and logistical challenges that dwarf nearly any other capital project. Even health care systems with deep pockets might not have sufficient land available, particularly in urban areas.

By 2018, the number of sites providing proton therapy in the US is expected to cross 25. Still, industry experts believe that players will miss out on a majority of cancer patients who can benefit with proton therapy, overlooking a huge multi Billion dollar potential market. In Unites States the numbers of patients treated with Proton Therapy is very low whereas; the potential candidates for proton therapy are in Millions. IBA dominates the proton therapy market in United States while in Japan Mitsubishi is the leading player. However other players like Varian, Mevion, Hitachi etc. have also started to make their presence felt in the market. The increased demand for proton therapy has motivated many prominent cancer centers in the world to provide proton therapy treatment. The number of proton therapy centers worldwide is anticipated to increase year on year with an ever-increasing number of patients.

iGATE RESEARCH report entitled Global Proton Therapy Market and Centers Analysis provides a comprehensive assessment of the fast-evolving, high-growth Proton Therapy Market. This 126 page report with 29 Figures and 10 Tables studies in detail the Global Proton Therapy Market.

The Report covers the Global Total Number of Patients Treated with Proton Therapy - Country Wise

The countries United States and Japan has been studied from 4 view points

Actual and Potential Proton Therapy Market
Actual and Potential Candidate for Proton Therapy Treatment
List of Proton Therapy Centers
Proton Therapy Company Analysis

The South Korea has been studied from 3 view points

Potential Proton Therapy Market
Potential Candidate for Proton Therapy Treatment
List of Proton Therapy Centers

In United States, 5 Companies is studied according to the Proton Therapy Centers developed by them:

IBA Proton Therapy
Optivus Proton Therapy
Hitachi Proton Therapy
Mevion Proton Therapy
Varian Proton Therapy

In Japan, 3 Companies is studied according to the Proton Therapy Centers developed by them:

IBA Proton Therapy
Mitsubishi Proton Therapy
Hitachi Proton Therapy

The Asia, Europe and South Africa Proton Therapy Centers Analysis - This section covers the List of Proton Therapy Centers, Proton Therapy Company, Specification and Start of Treatment

China
Australia
India
Saudi Arabia
Russia
Sweden
France
Netherlands
Italy
Poland
Germany
Czech Republic
Austria
Scandinavia
South Africa

Source of Information

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government And NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries And Local Councils and a large number of Paid Databases.

Table Of Contents

Global Proton Therapy Market and Centers Analysis
1. Executive Summary

2. Global Proton Therapy Analysis

2.1 Global Total Number of Patients Treated With Proton Therapy - Country Wise

3. United States Proton Therapy Market - Actual and Potential Market

3.1 United States - Proton Therapy Market
3.2 United States - Potential Proton Therapy Market

4. United States Proton Therapy Patient Number - Actual and Potential

4.1 United States - Patients Treated with Proton Therapy Actual Numbers and Forecast
4.2 United States - Patients with Proton Therapy Potential Numbers and Forecast

5. United States - List of Proton Therapy Centers, Cost, Start of Treatment, Patient Treated

6. Proton Therapy - Comparative Analysis of Company

7. United States Proton Therapy - Company Analysis

7.1 IBA Proton Therapy

7.1.1 IBA Proton Therapy Sales (2007 - 2015)
7.1.2 The Proton Therapy Centers Developed by IBA

7.2 Optivus Proton Therapy

7.2.1 The Proton Therapy Centers Developed by Optivus

7.3 Hitachi Proton Therapy

7.3.1 The Proton Therapy Centers Developed by Hitachi

7.4 Mevion Proton Therapy

7.4.1 The Proton Therapy Centers Developed by Mevion

7.5 Varian Proton Therapy

7.5.1 The Proton Therapy Centers Developed by Varian

8. Proton Therapy - Reimbursement Policies

9. Asia Proton Therapy Market Analysis

9.1 Japan Proton Therapy Market - Actual and Potential Market

9.1.1 Japan - Proton Therapy Actual Market and Forecast
9.1.2 Japan - Potential Proton Therapy Market

9.2 Japan Proton Therapy Patient Number - Actual and Potential

9.2.1 Japan - Patient Treated with Proton Therapy Actual Number and Forecast
9.2.2 Japan - Potential Candidate for Proton Therapy

9.3 Japan - List of Proton Therapy Centers, Cost, Start of Treatment

9.4 Japan Proton Therapy - Company Analysis

9.4.1 The Proton Therapy Centers Developed by Mitsubishi
9.4.2 The Proton Therapy Centers Developed by IBA
9.4.3 The Proton Therapy Centers Developed by Hitachi

9.5 South Korea - Potential Proton Therapy Market

9.6 South Korea - Potential Candidate for Proton Therapy

9.7 South Korea - Proton Therapy Centers Analysis

10. Asia Proton Therapy Centers Analysis

10.1 China Proton Therapy Centers Analysis
10.2 Australia Proton Therapy Centers Analysis
10.3 India Proton Therapy Centers Analysis
10.4 Saudi Arabia Proton Therapy Centers Analysis

11. Europe Proton Therapy Centers Analysis

11.1 Russia Proton Therapy Centers Analysis
11.2 Sweden Proton Therapy Centers Analysis
11.3 France Proton Therapy Centers Analysis
11.4 Netherlands Proton Therapy Centers Analysis
11.5 Italy Proton Therapy Centers Analysis
11.6 Poland Proton Therapy Centers Analysis
11.7 Germany Proton Therapy Centers Analysis
11.8 Czech Republic Proton Therapy Centers Analysis
11.9 Austria Proton Therapy Centers Analysis
11.10 Scandinavia Proton Therapy Centers Analysis

12. South Africa Proton Therapy Centers Analysis

13. Components of a Standard Proton Therapy Center

13.1 Proton Accelerator
13.2 Beam Transport System
13.3 Beam Delivery System

13.3.1 The Passive Scattering Technique
13.3.2 Beam Scanning

13.4 Nozzle

13.4.1 Single Scattering
13.4.2 Double Scattering
13.4.3 Uniform Scanning Nozzle
13.4.4 Pencil Scanning Nozzle

13.5 Treatment Planning System
13.6 Image Viewers
13.7 Patient Positioning System (PPS)
13.8 Human Resource

14. Proton Therapy - Driving Factors

14.1 Technology Advancement
14.2 Growing Incidence of Cancer Patients
14.3 Proton Therapy Provides Enormous Benefits

15. Proton Therapy - Challenges

15.1 Requires Huge Investment
15.2 Operations Challenges

List of Figures:

Figure 2-1: By Country - Total Patients Treated With Charged Particles (Number), 2013

Figure 3-1: United States - Proton Therapy Market (Million US$), 2009 - 2013
Figure 3-2: United States - Forecast for Proton Therapy Market (Million US$), 2014 - 2018
Figure 3-3: United States - Potential Proton Therapy Market (Million US$), 2009 - 2013
Figure 3-4: United States - Forecast for Potential Proton Therapy Market (Million US$), 2014 - 2018

Figure 4-1: United States - Patient Treated with Proton Therapy (Number), 2009 - 2013
Figure 4-2: United States - Forecast for Patient Treated with Proton Therapy (Number), 2014 - 2018
Figure 4-3: United States - Potential Candidate for Proton Therapy (Number), 2009 - 2013
Figure 4-4: United States - Forecast for Potential Candidate for Proton Therapy (Number), 2014 - 2018

Figure 7-1: United States - IBA Proton Therapy Sales (Million US$), 2007 - 2013
Figure 7-2: United States - Forecast for IBA Proton Therapy Sales (Million US$), 2014 - 2015

Figure 9-1: Japan - Proton Therapy Market (Million US$), 2003 - 2013
Figure 9-2: Japan - Forecast for Proton Therapy Market (Million US$), 2014 - 2018
Figure 9-3: Japan - Potential Proton Therapy Market (Million US$), 2005 - 2013
Figure 9-4: Japan - Forecast for Potential Proton Therapy Market (Million US$), 2014 - 2018
Figure 9-5: Japan - Patient Treated with Proton Therapy (Number), 2003 - 2013
Figure 9-6: Japan - Forecast for Patient Treated with Proton Therapy (Number), 2014 - 2018
Figure 9-7: Japan - Potential Candidate for Proton Therapy (Number), 2005 - 2013
Figure 9-8: Japan - Forecast for Potential Candidate for Proton Therapy (Number), 2014 - 2018

Figure 9-9: South Korea - Potential Proton Therapy Market (Million US$), 2007 - 2013
Figure 9-10: South Korea - Forecast for Potential Proton Therapy Market (Million US$), 2014 - 2018
Figure 9-11: South Korea - Potential Candidate for Proton Therapy (Number), 2007 - 2013
Figure 9-12: South Korea - Forecast for Potential Candidate for Proton Therapy (Number), 2014 - 2018

Figure 14-1: Global - Number of Patient Diagnosed With Cancer (Million), 2009 - 2013
Figure 14-2: Global - Forecast for Number of Patient Diagnosed With Cancer (Million), 2014 - 2018
Figure 14-3: United States - Number of Patient Diagnosed With Cancer (Million), 2009 - 2013
Figure 14-4: United States - Forecast for Number of Patient Diagnosed With Cancer (Million), 2014 - 2018
Figure 14-5: Japan - Number of Patient Diagnosed With Cancer (Million), 2005 - 2013
Figure 14-6: Japan - Forecast for Number of Patient Diagnosed With Cancer (Million), 2014 - 2018

List of Tables:

Table 5-1: United States - Proton Therapy Facilities in Operation and in Development Phase

Table 6-1: Proton Therapy - Comparative Analysis of Company, 2014

Table 7-1: United States - IBA Proton Therapy Centers, 2001 - 2015
Table 7-2: United States - Hitachi Proton Therapy Centers, 2006 - 2016
Table 7-3: United States - Mevion Proton Therapy Centers
Table 7-4: United States - Varian Proton Therapy Centers, 2014 - 2016

Table 9-1: Japan - Proton Therapy Centers, (1994 - 2016)
Table 9-2: Japan - Mitsubishi Proton Therapy Centers, (1994 - 2016)
Table 9-3: Japan - IBA Proton Therapy Centers, 1998
Table 9-4: Japan - Hitachi Proton Therapy Centers, 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Colorectal Cancer KOL Insight 2016

Colorectal Cancer KOL Insight 2016

  • $ 8085
  • Industry report
  • October 2016
  • by Firstword Pharma

KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.